Healthcare ❯ Pharmaceuticals

Drug Regulation

FDA Quality Control Prescription Practices Product Recalls ANMAT Contaminated Medications Codeine-based Medications FDA Policies Compounding Consumer Safety

Supreme Court Lets Medicare Drug Price Negotiations Stand

The ruling keeps the Medicare negotiation program in force with any rollback likely requiring Congress.

Stories older than 24h

HHS Denies SSRI Ban Talks as Kennedy Unveils Push to Curb Prescribing

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

Delhi Seizes 2,104 Insulin Units Over Storage, Label Violations

FDA Warns 30 Telehealth Firms Over Misleading Ads for Compounded GLP-1 Drugs

GLP‑1 Use Under Scrutiny After Study on Tolerability and Delhi OTC Sales

DOJ Seeks Pause of Louisiana Abortion-Pill Lawsuit as FDA Reopens Mifepristone Review

Telangana Orders Stop-Use of Almont-Kid Syrup After Ethylene Glycol Found

Federal Police Allege Illegal Tirzepatide Imports by Unikka in 'Operation Slim' Targeting Influencer Doctor

Mexico’s FGR Links Lawyer to Bribery Case Over Alleged Offer to Cofepris Inspectors

MHRA Pulls Kids’ Magnesium Gummies Over Undeclared Melatonin

Fourth Circuit Affirms West Virginia’s Restriction on Abortion Pill Mifepristone

Judge Kreplak Orders 22 Raids to Seize Contaminated Fentanyl Vials

Second Policymakers’ Forum Showcases India’s Role as Global Vaccine Supplier and Regulator

NHS Weight-Loss Jab Prescriptions Near Three Million as Experts Raise Lifelong Use Concerns

France Launches Nationwide Campaign to Tackle Prolonged Benzodiazepine Use

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

Scams and Counterfeits Exploit Demand for Weight-Loss Drugs

FDA Declares End to Tirzepatide Shortage, Impacting Compounded Drug Market

Compounded Weight Loss Drugs Raise Safety and Ethical Concerns